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LETTER TO THE EDITOR
PANDEMIC INFLUENZA A/H1N1 VIRUS IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Dear Editor,
A new outbreak of flu, called pandemic influenza A/H1N1, has been 
reported throughout the world, affecting thousands of patients. Here, 
the authors describe for the first time a patient with systemic lupus 
erythematosus (SLE) and antiphospholipid syndrome who developed 
an A/H1N1 infection and had a positive outcome.
A 22-year old female patient, with SLE since the age of seven, 
characterized by malar rash, alopecia, arthritis, pericardial effusion, 
renal disease, anti-dsDNA and anti-ribosomal P antibodies, had been 
using chloroquine diphosphate (250 mg/day), azathioprine (150 mg/
day) and prednisone (5 mg/day), without active lupus at the time. At the 
age of 20 she had a stroke, with various positive dosages of IgG (64 and 
28GPL) and IgM (120 and 36MPL) anticardiolipin antibodies; she was 
treated with aspirin (300 mg daily). The patient came to our emergency 
room on August 11th, 2009, with a dry cough and fever. The physical 
examination revealed diffuse wheezing and snoring, with a normal 
respiratory frequency. The chest radiography revealed no pulmonary 
or pleural changes. SpO2 was 97%. A diagnosis of tracheobronchitis 
was performed, and antibiotic treatment with ceftriaxone (2 g/day) and 
clarithromycin (1 g/day) was also introduced. At that time, Brazil was 
at the peak of the pandemic influenza A/H1N1 outbreak and, due to 
the patient’s immunosuppressed state, oseltamivir was added (75 mg 
twice daily for five days), and a respiratory isolation was initiated. At 
that moment, the white blood cell count was 13,100 (neutrophils 8700, 
lymphocytes 2200 and monocytes 2000); platelets 302,000; creatine 
kinase (CK) 131 U/L (reference: 26-192 U/L); creatinine 0.61 mg/
dL (reference: 0.7-1.2 mg/dL); lactate dehydrogenase (LDH) 515 U/L 
(reference: 240-480 U/L); and C-reactive protein (CRP) 25.7 (reference: 
< 3 mg/L), which reached 50.4 mg/L after three days. The liver enzymes 
showed a slight increase in aspartate aminotransferase (AST) at 35 U/L 
(reference: < 35 U/L); alanine aminotransferase (ALT) 41 U/L (normal: 
< 31 U/L); alkaline phosphatase 137 U/L (reference: 35-104 U/L); and 
gamma-glutamyltransferase (gamma GT) 253 U/L (reference: 5-36 U/L). 
The abdominal ultrasound was normal. The serologies for hepatitis B 
and C, HIV, syphilis, rubella and toxoplasmosis were negative. Lupus 
remained inactive throughout the period, with activity index SLEDAI = 0, 
negative anti-dsDNA and anti-ribosomal P, and normal complement levels 
(C3: 140 mg/dL and C4: 36 mg/dL). The real-time reverse transcriptase-
polymerase chain reaction (rRT-PCR) in nasopharyngeal secretions 
was positive for the RNA of pandemic influenza A/H1N1. The patient 
remained hospitalized in respiratory isolation for nine days. By the end 
of this time, the patient was asymptomatic and was discharged. At this 
time, her blood tests showed normal liver enzymes, CK 74U/L, creatinine 
0.70 mg/dL and CRP 2.68 mg/L. Currently she is asymptomatic, using 
chloroquine, azathioprine and aspirin in the same dosages as previously 
and her prednisone has been reduced to 2.5 mg/day.
An outbreak of a new influenza, called pandemic influenza A/
H1N1, was reported in March 2009 by the World Health Organization. 
Later, it spread to 74 countries in a pandemic scenario, with a fatality 
rate of 0.5%3. In Brazil, 9,249 (20%) patients presented infection 
with novel influenza A (H1N1) virus. Seasonal influenza A infection 
was confirmed in 1,152 (2.5%) patients2. Individuals identified as 
being at high risk for complications and high mortality in pandemic 
influenza A/H1N1 infection are those under the age of two years 
old or more than 60 years old, pregnant women, those with chronic 
diseases such as chronic obstructive pulmonary disease, heart failure, 
and obesity and immunocompromised patients. This latter group 
includes two major problems: firstly, that there is an increased risk 
of mortality, and secondly, that two cases of oseltamivir resistance in 
immunosuppressed patients were already described and had prolonged 
viral shedding1. Lupus is an autoimmune disease characterized by 
immunosuppression due to different factors, including leukopenia and 
the use of immunosuppressive drugs. These findings, in theory, point 
out that lupus patients are at risk of contracting pandemic influenza A/
H1N1 infection; however, to date, no cases of this infection have been 
described in these patients.
In summary, this study describes for the first time a patient with SLE 
who had a mild infection caused by pandemic influenza A/H1N1 virus 
and had a satisfactory outcome. It is noteworthy that this infection in 
immunocompromised patients has been poorly studied, and more cases 
or case series must be published in order to clarify the history of this 
infection in SLE patients. 
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